Lifirafenib maleate
Based on 3 publication(s) in Google Scholar
Lifirafenib (BGB-283) maleate is a novel and potent Raf Kinase and EGFR inhibitor with IC50 values of 23 and 29 nM for recombinant BRafV600E and EGFR, respectively.
For research use only. We do not sell to patients.
- CAS No.: 1854985-74-2
- Formula: C25H17F3N4O3.3/2C4H4O4
- Molecular Weight:652.53
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Lifirafenib maleate
MoreAll EGFR Isoforms
More
Biological Activity
IC50: 23 nM (recombinant BRafV600E ), 29 nM (EGFR)[1]
Chemical Information
-
CAS No. 1854985-74-2
-
Molecular Weight 652.53
-
Formula C25H17F3N4O3.3/2C4H4O4
-
SMILES
O=C1NC2=NC=CC(OC3=CC=C(O[C@@]4([H])[C@]5([H])[C@@H]4C6=NC7=CC=C(C(F)(F)F)C=C7N6)C5=C3)=C2CC1.O=C(/C=C/C(O)=O)O.[1.5]
-
Synonyms
BGB-283 maleate
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (3)
-
Journal Impact Factor
-
Most Recent
-
J Mol Med (Berl)
The role and mechanism of TNFRSF21 in promoting necroptosis of vascular endothelial cells and inducing vascular leakage in sepsis. [Abstract]2026 Apr 23;104(1):68. PMID: 42020785 -
J Med Virol
Small molecule RAF265 as an antiviral therapy acts against HSV-1 by regulating cytoskeleton rearrangement and cellular translation machinery. [Abstract]2023 Jan;95(1):e28226. PMID: 36251738 -
bioRxiv
A structure-based modelling approach identifies effective drug combinations for RAS-mutant acute myeloid leukemia. [Abstract]2025 May 3:2025.04.29.651188. PMID: 40654850
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)